|
|
 |
 |
|
|
| |
 
The Therapeutic Goods Administration (TGA) is a unit of the Australian Government Department of Health and Ageing and is responsible for administering the provisions of the legislation. The Australian community expects that medicines and medical devices in the marketplace are safe and of high quality, and of a standard at least equal to that of comparable countries. The objective of the Therapeutic Goods Act 1989, which came into effect on 15 February 1991, is to provide a national framework for the regulation of therapeutic goods in Australia to ensure the quality, safety and efficacy of medicines.
Essentially therapeutic goods must be entered on the Australian Register of Therapeutic Goods (ARTG) listing before they can be sold in Australia. The ARTG is a computer database of information about therapeutic goods for human use approved for supply in, or exported from, Australia. Therapeutic goods are divided broadly into two classes - (i) medicines and medical devices and (ii) Complementary Medicines that comprise vitamins, mineral, herbal and other health supplements. Unless exempted, therapeutic goods must be entered as either 'registered' goods or 'listed' goods before they may be supplied in, or exported from Australia.
In order to be approved by TGA and to be listed on the ARTG listing, the medicines must be manufactured under pharmaceutical standards of Good Manufacturing Practice (GMP) with high standard of quality, safety as well as efficacy. Any claims made by the companies must be able to produce sufficient and sound supporting documents and evidences for TGA product assessment.
TGA is acclaimed to be one of the most stringent regulators on Complementary Medicines and products listed on ARTG are regarded as high quality products for safety and efficacy.
To view the listing of OLIVENOL™ livin', follow the link below to the ARTG website.
https://www.tgasime.health.gov.au/
|
| |
|
|
| |
|
OLIVENOL™ livin' has been granted GRAS status and during this determination the scientific evidence verifies the potency and safety of our patented Olea europaea biophenols extract.
"GRAS" is an acronym for the phrase Generally Recognized As Safe and is recognized by the US Food and Drug Administration (FDA). Any substance that is intentionally added to food is subject to pre market review and approval by FDA.
Read more on the GRAS report
|
 |
|
|
